FDA Approved: MITOXANTRONE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for MITOXANTRONE by Hospira, Inc., resulting in updated labeling for the product under the ANDA. The approval represents…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Hormone-refractory Prostate Cancer
• Multiple Sclerosis

Drugs mentioned

• Mitoxantrone (mitoxantrone)

Snippet

SUPPL AP for MITOXANTRONE (MITOXANTRONE)